# Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/troglitazone-inhibits-formation-of-early-atherosclerotic-lesions-in-diabetic-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alan R. Collins,Woerner P. Meehan,Ulrich Kintscher,Simon Jackson,Shu Wakino,Grace Noh,Wulf Palinski,Willa A. Hsueh,Ronald E. Law |
| Citations | 391 |
| DOI | 10.1161/01.atv.21.3.365 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1968243232 |
| PMID | 11231915 |
| Type | article |
| Year | 2001 |

## Paper authors

- [Shu Wakino](https://scholariq.org/researchers/shu-wakino/)

## Paper primary topic

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

## Paper topics

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.